Research on Virtual Screening of Natural Compounds Against Protozoan Parasites Using Comparative Genomics and Molecular Docking Techniques

Menghan He; Shuquan Guo

doi:10.62051/ijphmr.v2n3.07

Authors

Menghan He
Shuquan Guo

DOI:

https://doi.org/10.62051/ijphmr.v2n3.07

Keywords:

Parasitic protozoa, Virtual screening, Molecular docking, DHFR-thymidylate synthase

Abstract

This study aims to identify conserved drug targets in protozoan parasites through genomic data mining and use computational virtual screening to discover small molecule inhibitors from the TCMSP database that target these conserved drug targets. Comparative genomics was applied to identify key drug targets in protozoan parasites, and high-throughput screening was conducted using the AutoDock Vina molecular docking program. The results were further refined using docking scores and the "ADME-Lipinski" rule, followed by an analysis of the interactions between small molecules and the drug targets. Potential small molecules with anti-parasitic activity were predicted. In this study, the DHFR-TS enzyme was identified as a conserved drug target for protozoan parasites through comparative genomics. Using DHFR-TS as the target and a known positive control ligand, six compounds with favorable drug-like properties were selected from the TCMSP database: MOL013376, MOL005018, MOL009591, MOL002047, MOL011499, and MOL012692. These compounds demonstrated superior binding affinity and interaction with DHFR-TS compared to the positive control ligand. This study combines comparative genomics and computational virtual screening to identify potential natural compounds from Traditional Chinese Medicine for protozoan parasites, providing a solid theoretical foundation for the design and experimental synthesis of novel anti-parasitic drug candidates.

References

[1] Barrett M P, Burchmore R J S, Stich A, et al. The trypanosomiases [J]. The Lancet, 2003, 362(9394): 1469-1480.

[2] Baneth G, Yasur-Landau D, Gilad M, et al. Canine leishmaniosis caused by Leishmania major and Leishmania tropica: comparative findings and serology [J]. Parasites & Vectors, 2017, 10: 1-9.

[3] Xiao J, Yolken R H. Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases [J]. Acta physiologica, 2015, 213(4): 828-845.

[4] Nonaka M, Murata Y, Takano R, et al. Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts [J]. Malaria Journal, 2018, 17(1): 1-10.

[5] Comparative genomics of the major parasitic worms [J]. Nature genetics, 2019, 51(1): 163-174.

[6] Hardison R C. Comparative genomics [J]. PLoS biology, 2003, 1(2): e58.

[7] Meng X Y, Zhang H X, Mezei M, et al. Molecular docking: a powerful approach for structure-based drug discovery [J]. Current computer-aided drug design, 2011, 7(2): 146-157.

[8] Xu L, Dong Z, Fang L, et al. OrthoVenn2: a web server for whole-genome comparison and annotation of orthologous clusters across multiple species [J]. Nucleic acids research, 2019, 47(W1): W52-W58.

[9] Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines [J]. Journal of cheminformatics, 2014, 6: 1-6.

[10] Zaware N, Sharma H, Yang J, et al. Discovery of potent and selective inhibitors of Toxoplasma gondii thymidylate synthase for opportunistic infections [J]. ACS medicinal chemistry letters, 2013, 4(12): 1148-1151.

[11] Trott O, Olson A J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading [J]. Journal of computational chemistry, 2010, 31(2): 455-461.

[12] Vugmeyster Y, Harrold J, Xu X. Absorption, distribution, metabolism, and excretion (ADME) studies of biotherapeutics for autoimmune and inflammatory conditions [J]. The AAPS journal, 2012, 14: 714-727.

[13] Lipinski C. Solubility in the design of combinatorial libraries [J]. Analysis and Purification Methods in Combinatorial Chemistry, 2003, 163: 407-434.

[14] Burgess S L, Gilchrist C A, Lynn T C, et al. Parasitic protozoa and interactions with the host intestinal microbiota [J]. Infection and immunity, 2017, 85(8): 101-108.

[15] Short E E, Caminade C, Thomas B N. Climate change contribution to the emergence or re-emergence of parasitic diseases [J]. Infectious Diseases: Research and Treatment, 2017, 10: 1178633617732296.

[16] Schaap P, Schilde C. Encystation: the most prevalent and underinvestigated differentiation pathway of eukaryotes [J]. Microbiology, 2018, 164(5): 727-739.

[17] Striepen B, Kissinger J C. Genomics meets transgenics in search of the elusive Cryptosporidium drug target [J]. Trends in parasitology, 2004, 20(8): 355-358.